NeuropsychopharmacologyPharmacology & ToxicologyPeer-reviewed journal article
RAPID HIPPOCAMPAL SYNAPTIC POTENTIATION INDUCED BY KETAMINE METABOLITE (2R,6R)-HYDROXYNORKETAMINE PERSISTENTLY PRIMES SYNAPTIC PLASTICITY
Abstract
The pharmacologically active (R,S)-ketamine (ketamine) metabolite (2R,6R)-hydroxynorketamine (HNK) maintains ketamines preclinical antidepressant profile without adverse effects. While hypotheses have been proposed to explain how ketamine and its metabolites initiate their antidepressant-relevant effects, it remains unclear how sustained therapeutic actions arise following drug elimination. To distinguish the physiological mechanisms involved in the rapid from sustained actions of HNK, we utilized extracellular electrophysiology combined with pharmacology to develop an in vitro hippocampal slice incubation model that exhibited pharmacological fidelity to the 1) rapid synaptic potentiation induced by HNK at the Schaffer collateral-CA1 (SC-CA1) synapse during bath-application to slices collected from mice, and 2) maintenance of metaplastic (priming) activity that lowered the threshold for N-methyl-D-aspartate receptor (NMDAR) activation-dependent long-term potentiation (LTP) hours after in vivo dosing. We then used this model to reveal novel druggable mechanisms engaged in HNKs temporally-sensitive antidepressant synaptic actions, finding that the induction of synaptic potentiation by HNK did not require NMDAR activity, but NMDAR activity was necessary to maintain synaptic priming. HNK required protein kinase A (PKA) activity to rapidly potentiate SC-CA1 neurotransmission to facilitate synaptic priming that persistently promoted LTP formation. HNKs rapid actions were blocked by inhibitors of adenylyl cyclase 1 (AC1), but not an AC5 inhibitor. We conclude that HNK rapidly potentiates SC-CA1 synaptic efficacy, which then stimulates priming mechanisms that persistently favor antidepressant-relevant plasticity. Targeting such priming mechanisms may be an effective antidepressant strategy, and using approaches such as our incubation model may aid in revealing novel pharmacological targets.
- organism: mouse
- assay: electrophysiology
- research focus: synaptic & neural circuits
- approach: experimental assay
- Citations
- 15
- FWCI
- 7.60
- Field percentile
- top 2%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Ketamines rapid antidepressant effects are mediated by Ca2+ - permeable AMPA receptors in the hippocampus
Anastasiya Zaytseva, Evelina Bouckova, … Seonil Kim·eLifePeer-reviewed·Jun 26, 2023
- (2R,6R)-Hydroxynorketamine elicits rapid antidepressant effects by promoting astrocytic μ-δ opioid receptor heterodimerization
Yanxia Liang, Lingjun Wang, … Xiang Cai·bioRxiv·Jun 3, 2026
- Ketamine selectively enhances AMPA neurotransmission onto a subgroup of identified serotoninergic neurons of the rat dorsal raphe
Cyrine Hmaied, Stanislav Koulchitsky, … Vincent Seutin·bioRxiv·Aug 19, 2020
- Ketamine strengthens synaptic inputs to the dorsal raphe to boost serotonergic activity: pivotal for rapid antidepressant-like effects
Soukaina Es-Safi, Céline Bourcier‐Lucas, … Guillaume Lucas·bioRxiv·Oct 24, 2025
- Astrocytic μ-δ opioid receptor heterodimers mediate the antidepressant effects of ketamine's metabolite
Shuo Yang, Ling Jun Wang, … Q Zhou·bioRxiv·Jun 3, 2026
- Fast-acting antidepressants trigger presynaptic BDNF release and structural plasticity at mouse mossy fiber-CA3 synapses
Irem L Atasoy-Rodriguez, Kenneth W. Johnson, … Jimcy Platholi·bioRxiv·Mar 2, 2026